Explore

Trendline Trendline
EyePoint Pharmaceuticals Reports Q1 2026 Financial Results Amid Clinical Progress

EyePoint Pharmaceuticals Reports Q1 2026 Financial Results Amid Clinical Progress

EyePoint Pharmaceuticals Reports Q1 2026 Financial Results Amid Clinical Progress
Trendline Trendline
DiaMedica Therapeutics Reports Q1 2026 Financial Results and Clinical Progress

DiaMedica Therapeutics Reports Q1 2026 Financial Results and Clinical Progress

DiaMedica Therapeutics Reports Q1 2026 Financial Results and Clinical Progress
Trendline Trendline
Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies

Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies

Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies
Trendline Trendline
Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline
Trendline Trendline
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches

Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches

Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Trendline Trendline
Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs

Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs

Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs
Trendline Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Trendline Trendline
Janux Therapeutics Reports Q1 2026 Financial Results and Pipeline Progress

Janux Therapeutics Reports Q1 2026 Financial Results and Pipeline Progress

Janux Therapeutics Reports Q1 2026 Financial Results and Pipeline Progress
Trendline Trendline
Novavax Exceeds Q1 2026 Expectations Despite Revenue Decline

Novavax Exceeds Q1 2026 Expectations Despite Revenue Decline

Novavax Exceeds Q1 2026 Expectations Despite Revenue Decline
Trendline Trendline
Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark

Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark

Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark
Trendline Trendline
Viridian Therapeutics Launches Public Offerings to Raise Funds for Autoimmune and Rare Disease Treatments

Viridian Therapeutics Launches Public Offerings to Raise Funds for Autoimmune and Rare Disease Treatments

Viridian Therapeutics Launches Public Offerings to Raise Funds for Autoimmune and Rare Disease Treatments
Trendline Trendline
Stevanato Group to Participate in Three Major Investor Conferences

Stevanato Group to Participate in Three Major Investor Conferences

Stevanato Group to Participate in Three Major Investor Conferences